
V3bio is a 100% Malaysian owned manufacturer of medical devices focusing on advanced wound management and other infection control products for various industry and healthcare applications.
Established in 2020 by entrepreneurs with over 30 years’ experience in medical devices and infection control products development, manufacturing and marketing. Within relatively a short period of time, V3bio has attained ISO 13485 US FDA, Halal, MDA registration, and MySTI certifications.
V3bio capabilities include design, development and manufacturing. The platform technology, e-HOCl, which is a performance stabilized hypochlorous acid technology, has been the core competency of V3bio. Based on e-HOCl technology, various innovative applications have been derived to further improve healthcare and infection control needs.
V3bio will continue to develop high quality, innovative yet affordable range of products to meet various applications especially in healthcare segment while complying to various international and country specific regulatory requirements. V3bio will also expand its manufacturing capacity with investments in automation, human capital and adopting IR 4.0. In line with this, V3bio’s products will be poised for entry into more international markets expansions.

To contribute to the healthcare and other industry development with expertise, safe and innovative products which meet the present-day needs

At V3bio, quality is at the core of everything we do. We are committed to delivering safe, effective, and reliable medical products through stringent quality control systems and continuous improvement processes. Our manufacturing and product development practices comply with internationally recognized standards, and we have obtained key regulatory approvals and certifications that reflect our dedication to excellence. By adhering to these high standards, we ensure consistent product performance, build trust with healthcare professionals, and ultimately support better patient outcomes.